
Tuesday, May 13, 2025 5:52:34 PM
TORONTO, May 13, 2025 — Two Hands Corporation (“Two Hands” or the “Company”) (CSE:
TWOH.X) (OTC: TWOH) announces that effective May 2, 2025, it has converted an aggregate of
US$850,972.01 of principal and accrued and unpaid interest into 170,194,403 shares of common
stock of the Company (“Common Shares”) at a deemed price of US$0.005 per Common Share,
pursuant to the terms of a grid promissory note and credit facility agreement dated April 14, 2022, as
amended on December 30, 2024 (the “Convertible Note”). The Convertible Note is described in the
Company’s listing statement dated August 3, 2022, which is available on SEDAR+ at
www.sedarplus.ca.
The issuance of the Common Shares is subject to the acceptance of the CSE.
Recent TWOH News
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/14/2025 09:13:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/13/2025 04:14:58 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/02/2025 08:43:22 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 04/14/2025 08:58:19 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/07/2025 07:32:06 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/31/2025 12:35:31 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 03/14/2025 06:44:17 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 03/14/2025 06:43:35 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 02/28/2025 11:12:00 AM
- Form 8-K/A - Current report: [Amend] • Edgar (US Regulatory) • 01/24/2025 01:19:53 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/10/2025 04:13:35 PM
- Form SCHEDULE 13D - General Statement of Acquisition of Beneficial Ownership • Edgar (US Regulatory) • 01/10/2025 04:09:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/30/2024 09:12:49 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/18/2024 10:18:48 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 11/14/2024 09:03:41 PM
Branded Legacy Inc. Announces Leadership Transition and Pending Merger with Innovative Addiction Therapeutics Company Projecting $40 Million in First-Year Revenue • BLEG • Jul 14, 2025 1:23 PM
VAYK Project 100% Revenue Growth Before Half Year Report • VAYK • Jul 14, 2025 8:58 AM
Glidelogic Corp. Announces Release of First AI-Generated Novel "The Thirteenth Proposal" • GDLG • Jul 11, 2025 12:20 PM
Fifty1 AI Labs' REVIVE Clinical Trial Redefines Long COVID Treatment, Pioneering AI-Driven Therapies and Propelling Fifty 1 Labs, Inc. Toward $50M Valuation and Global Biotech Leadership • FITY • Jul 10, 2025 8:30 AM
Aspire Biopharma Holdings, Inc., Announces Positive Consumer Feedback from Company Sampling of BUZZ BOMB™, its New Sublingual Pre-Workout Supplement • ASBP • Jul 9, 2025 9:15 AM
Breaking Through: Systemic Genetic Medicines for Hard-to-Treat Cancers • IBRX • Jul 9, 2025 9:00 AM